Supplementary Figure S1C: Generation of stable cell lines. Western blots of individual cell lines of HeLa cells (wt-PIK3CA)
stably overexpressing PIK3CA-E545K. HeLa cells were transfected with PIK3CA-E545K and stable cell lines were generated by selection on G418 (400 µg/ml). Sequencing showed that all clones were positive for the E545K mutation. Cell extracts were analyzed by western blot with the antibodies indicated on the right. Further experiments were carried out with clone 6 (indicated by *). Figure 2A showing expression of p110α, p110β, PTEN, p85 and Akt/pS473-Akt in A5, A5-wt and A5-E545K cell lines. In each experiment, signals on western blot were normalized to Ku80 (loading control) and the mean from 3 separate experiments is shown. Black bars indicate A5-E545K cells, gray bars A5-WT cells and white bars A5 cells. The presence of the # symbol indicates where the white bars are below the limits of detection (e.g. p110α, Myc and pAkt)/total Akt). Error bars denote S.E.M. statistical significance was determined using multiple t-tests with the Holm-Sidak method to correct for multiple comparisons. p values for expression of p110α, Myc and phosphoAkt/Total Akt in A5-E545K cells (black bars) versus A5 (white bars) were 0.002, 0.0009 and 0.00018 respectively. p values for expression of p110α, Myc and phosphoAkt/Total Akt for A5-WT cells (gray bars) compared to A5 cells (white bars) were 0.0029, 0.0019 and <0.0001 respectively. P values < 0.05 were considered statistically significant and are indicated by the asterisks. B. Quantitation of western blots in Figure 3A showing expression of p110α, p110β, PTEN, p85 and Akt/pS473-Akt in HeLa-E545K (black bars), A5-E545K (gray bars) and A5-WT (white bars) cell lines. In each experiment, signals from western blot were normalized to Ku80 (loading control) and the mean from 3 separate experiments is shown. No statistically significant difference in protein expression was observed between the 3 cell lines. Figure S3 : Cervical cancer cells expressing PIK3CA-E545K retain residual Akt and RSK phosphorylation after serum starvation. A5-WT (HeLa cells with shRNA depletion of endogenous PIK3CA and stable expression of PIK3CA-WT), A5-E545K (HeLa cells with shRNA depletion of PIK3CA and stable expression of shRNA resistant PIK3CA-E545K, panels A. and C. and HeLa-E545K (HeLa cells stable expressing PIK3CA-E545K, panels B. and d. cells were grown in 5% serum then placed in media containing 2% serum for 48 hours, followed by media containing 0.2% serum for 48 hours. Extracts were made and assayed by western blot for either Akt-pS473 and total Akt (panels A and B) or RSK-pS380 and total RSK (panels C and D). In each experiment, phosphorylation of Akt or RSK was quantitated, normalized to Ku80 (loading control) and the mean from 3 separate experiments is shown below each representative experiment. Error bars denote S.E.M. The graphs show relative phosphorylation of Akt or RSK for each cell line at 5% and 0.2% serum. The percent phosphorylation at 0.2% serum relative to phosphorylation at 5% serum is indicated on the graphs. Statistical significance was determined using two-tailed un-paired t-tests. p values for changes in phosphorylation at 5% serum compared to 0. (PIK3CA-WT plus PIK3CA-E545K) and CaSki (PIK3CA-WT plus PIK3CA-E545K) were seeded on 6 cm plates and 24 hours later incubated with either GDC-0941 (final concentration GDC 0.5 µM and DMSO 0.01%) or DMSO vehicle control (final concentration 0.01%). After 24 hours, media was replaced with fresh media and the plates were incubated at 37°C, under 5% CO 2 . After 14 days, the plates were fixed, stained and colonies were counted as above. Results are expressed as mean ± SEM for each GDC-0941 treated cell line normalized to its own DMSO treated control. The % survival after GDC-0941 treatment for each cell line (relative to its own DMSO control) is shown in the graph. Statistical significance was determined using a two-tailed homoscedastic t-test. All results were highly significant, p values < 0.001 are indicated by ** and <0.0001 by ***. HeLa cells overexpressing PIK3CA-E545K (HeLa-E545K) were seeded on 6 cm plates and 24 hours later treated with either control PBS (154 mM NaCl) or cisplatin (formulated in PBS) at 1 μM and GDC-0941 at 0.5 µM respectively. After 24 hours, media was replaced with fresh media and plates were incubated at 37°C, under 5% CO 2 . After 14 days, the plates were fixed, stained and colonies were counted as above. The results show the means of three separate experiments with standard deviation. Statistical significance was determined using ordinary one-way ANOVA with Dunnett's multiple comparison test. For each cell lines different treatment conditions were compared to the control group. In A5-WT, DMSO vs PBS, the p value was <0.05. For DMSO vs. Cisplatin/PBS and DMSO, vs. GDC-0941/DMSO, and vs. Cisplatin/PBS and GDC-0941/DMSO, the p value was <0.0001. In A5-E545K, DMSO vs PBS, vs. Cisplatin/PBS and DMSO, vs. GDC-0941/DMSO, and vs. Cisplatin/PBS and GDC-0941/DMSO, the p value was <0.0001. In HeLa-E545K, DMSO vs PBS, the p value was <0.01. For DMSO vs. Cisplatin/PBS and DMSO, vs. GDC-0941/DMSO, and vs. Cisplatin/PBS and GDC-0941/DMSO, the p value was <0.0001. A5-E545K cells were grown to confluency on 6 cm plates. Scratches were made and wound healing was observed 0, 6, 24, and 48 hours after initiation of the scratch. The rate of migration was measured by quantifying the total distance between the edges of the scratch at each time point. Scale bars = 100 µm. B. Average scratch widths, normalized to the width at 0 hours, from three separate experiments with standard deviation are shown using ordinary one way ANOVA with Dunnett's multiple comparison test. All the time points were compared to the 0hr time point. For A5 at 0hr vs 6hr is *, 0hr vs 24hr is ** and 0hr vs 48hr is *** respectively. p values of <0.05 are represented by *, <0.01 represents ** and <0.001 represents *** respectively. C. Average scratch widths, normalized to the width at 0 hours, from three separate experiments with standard deviation are shown using ordinary one way ANOVA with Dunnett's multiple comparision test. All the time points were compared to the 0hr time point. For A5-WT at 0hr vs 6hr is *, 0hr vs 24hr is ** and 0hr vs 48hr is *** respectively. p values of <0.05 are represented by *, <0.01 represents ** and <0.001 represents *** respectively. d. Average scratch widths, normalized to the width at 0 hours, from three separate experiments with standard deviation are shown using ordinary one way ANOVA with Dunnett's multiple comparision test. All the time points were compared to the 0hr time point. For A5-E545K at 0hr vs 6hr is **, 0hr vs 24hr is *** and 0hr vs 48hr is **** respectively. p values of <0.01 represents **, <0.001 represents *** and <0.0001 represents **** respectively. equivalent volume of DMSO (final concentration 0.01%) as control, treated with radiation (2 Gy) and cisplatin (formulated in PBS) at 1 μM or treated with 1 µM GDC-0941 (formulated in DMSO) radiation (2 Gy) and cisplatin (formulated in PBS) at 1 μM. After twenty four hours media was removed and replaced with fresh media and scratches were made with a sterile 200 µL pipette tip. Cells were harvested by 24 and 48 hours later as indicated in the figure. In each case, an aliquot of cells was mixed with trypan blue (0.4%) and the percentage of viable cells was determined using automated cell counter (Bio-Rad TC10). At the 48 hour time point, the viability of HeLa cells treated with cisplatin plus IR was 91.2% compared to the mock treated controls. For HeLa cells treated with cisplatin/IR and GDC, the % viability was 82%. For CaSki cells the % viability was 102% (minus GDC) and 68% plus GDC and for HeLa-E545K, the viability was 108% minus GDC and 74% plus GDC. The results suggest that GDC-0941 reduces the viability of cells bearing the PIK3CA-E545K mutation by approximately 30% compared to cells with PIK3CA-wt. Whether this is due to reduced proliferation or enhanced cell death remains to be determined.
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